Impulse Biomedical

Image

 Impulse Biomedical is the force behind breakthrough devices that are reshaping emergency care. Their flagship products include the Easy Squeezy, an affordable and easy-to-use asthma inhaler that empowers patients to manage asthma more effectively, and the ZiBiPen, the world’s first reloadable epinephrine auto-injector. 


Location: South Africa
Website: https://www.impulsebiomed.com/
Sector: Healthcare
Funding Stage: Venture Round, Venture Round, Venture Round,
Total Funding ($m): 1.6
# of Founders: 2
Founding Year: 2017
Funding Year: 2025
Status: Active
YearAmountStageInvestors
2021$1.5mVenture RoundFuturegrowth Asset Management and others
2022$0.1mVenture RoundLaunch Africa
2025$UndisclosedmVenture Round E Squared Investments and ANZA Capital
Profile Picture
Gokul Nair
Co-Founder & CEO
Profile Picture
Venture Round $1.5m
Futuregrowth Asset Management and others

Venture Round $0.1m
Launch Africa

Venture Round $Undisclosedm
 E Squared Investments and ANZA Capital



News
https://disruptafrica.com/2025/05/16/sa-med-tech-startup-impulse-biomedical-secures-funding-to-commercialise-expand/